Related Experiment Video

Updated: May 19, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

[Risk stratification in Chagas disease]

Marcia M Barbosa1, Maria Carmo P Nunes

  • 1ECOCENTER, Hospital Socor, Belo Horizonte, Minas Gerais, Brasil. marciambarbosa@terra.com.br

Revista Espanola De Cardiologia (English Ed.)
|August 28, 2012
PubMed

Insights

Chagas disease causes infectious myocarditis, leading to heart failure and sudden death. Identifying poor prognostic markers, particularly echocardiographic predictors, is crucial for managing patient risk.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Chagas disease is a primary global cause of infectious myocarditis.
  • It leads to significant morbidity and mortality, presenting a major public health challenge.
  • Clinical outcomes and prognosis in Chagas disease patients vary considerably.

Purpose of the Study:

  • To review risk stratification strategies for Chagas disease.
  • To highlight echocardiographic predictors of mortality in affected individuals.
  • To aid clinical decision-making by identifying markers of poor prognosis.

Main Methods:

  • This article presents a concise review of existing literature.
  • The focus is on studies identifying risk stratification methods.
  • Echocardiographic findings as mortality predictors are specifically examined.

Main Results:

  • Risk stratification is essential for managing Chagas disease patients.
  • Echocardiography offers valuable insights into prognosis.
  • Specific echocardiographic parameters can predict mortality risk.

Conclusions:

  • Accurate risk stratification improves patient management in Chagas disease.
  • Echocardiographic predictors are vital for identifying high-risk individuals.
  • Further research into prognostic markers can reduce Chagas disease mortality.

More Related Videos

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies07:59

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...